Rassy E - Search Results

1

Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions.

Rassy E, Le Roy F, Smolenschi C, Valéry M, Boige V, Ducreux M, Boilève A. Rassy E, et al. JAMA Oncol. 2023 Mar 1;9(3):434-435. doi: 10.1001/jamaoncol.2022.7136. JAMA Oncol. 2023. PMID: 36701137 Free PMC article.

2

Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?

Smolenschi C, Rassy E, Pallud J, Dezamis E, Copaciu R, Parker F, Garcia G, Lezghed N, Colomba E, Khettab M, Ammari S, Fekhi M, Martanovschi L, Benadhou L, Knafo S, Guyon D, Cheaib B, Dhermain F, Dumont SN. Smolenschi C, et al. Among authors: rassy e. J Neurol. 2023 May;270(5):2702-2714. doi: 10.1007/s00415-023-11600-w. Epub 2023 Feb 22. J Neurol. 2023. PMID: 36813928

3

The educational contribution of the college of the European school of oncology (ESCO): A survey analysis of the first three years.

Hall C, Eniu A, Rassy E, Cavalli F, Costa A, Peccatori F, Rolfo C, Pavlidis N. Hall C, et al. Among authors: rassy e. Crit Rev Oncol Hematol. 2023 Dec;192:104145. doi: 10.1016/j.critrevonc.2023.104145. Epub 2023 Oct 1. Crit Rev Oncol Hematol. 2023. PMID: 37783317 Review.

4

The paradigm shift to precision oncology between political will and cultural acceptance.

Rassy E, Heard JM, Andre F. Rassy E, et al. ESMO Open. 2023 Oct;8(5):101622. doi: 10.1016/j.esmoop.2023.101622. Epub 2023 Aug 24. ESMO Open. 2023. PMID: 37625196 Free PMC article. No abstract available.

5

A forgotten dimension of big data in drug repositioning.

Rassy E, Andre F. Rassy E, et al. Eur J Cancer. 2023 Oct;192:113277. doi: 10.1016/j.ejca.2023.113277. Epub 2023 Aug 6. Eur J Cancer. 2023. PMID: 37647850 No abstract available.

6

Impact of radiation therapy on healthy tissues.

Chargari C, Rassy E, Helissey C, Achkar S, Francois S, Deutsch E. Chargari C, et al. Among authors: rassy e. Int Rev Cell Mol Biol. 2023;376:69-98. doi: 10.1016/bs.ircmb.2022.11.006. Epub 2022 Dec 30. Int Rev Cell Mol Biol. 2023. PMID: 36997270

7

Predicting tumour origin with cytology-based deep learning: hype or hope?

Rassy E, Pavlidis N. Rassy E, et al. Nat Rev Clin Oncol. 2024 May 21. doi: 10.1038/s41571-024-00906-x. Online ahead of print. Nat Rev Clin Oncol. 2024. PMID: 38773339 No abstract available.

8

Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma - A Meta-analysis.

Eden D, Ghose A, Moschetta M, Pérez-Fidalgo JA, Rassy E, Boussios S. Eden D, et al. Among authors: rassy e. Anticancer Res. 2024 Mar;44(3):861-878. doi: 10.21873/anticanres.16880. Anticancer Res. 2024. PMID: 38423658 Review.

9

Forget lung, breast or prostate cancer: why tumour naming needs to change.

André F, Rassy E, Marabelle A, Michiels S, Besse B. André F, et al. Among authors: rassy e. Nature. 2024 Feb;626(7997):26-29. doi: 10.1038/d41586-024-00216-3. Nature. 2024. PMID: 38347121 No abstract available.

10

Telehealth in breast cancer following the coronavirus disease 2019 pandemic.

Zeghondy J, Rassy E, Lapidari P, Eid R, Pistilli B. Zeghondy J, et al. Among authors: rassy e. Explor Target Antitumor Ther. 2023;4(6):1249-1259. doi: 10.37349/etat.2023.00195. Epub 2023 Dec 26. Explor Target Antitumor Ther. 2023. PMID: 38213534 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page